as 06-20-2025 3:34pm EST
Founded: | 2018 | Country: | United States |
Employees: | N/A | City: | BRISBANE |
Market Cap: | N/A | IPO Year: | 2021 |
Target Price: | $31.57 | AVG Volume (30 days): | 1.2M |
Analyst Decision: | Strong Buy | Number of Analysts: | 7 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -0.71 | EPS Growth: | N/A |
52 Week Low/High: | $6.08 - $16.76 | Next Earning Date: | 07-29-2025 |
Revenue: | $161,922,000 | Revenue Growth: | N/A |
Revenue Growth (this year): | 17.98% | Revenue Growth (next year): | 49.50% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Dubow Adam | DAWN | GENERAL COUNSEL | May 15 '25 | Sell | $6.26 | 4,552 | $28,485.96 | 47,136 | |
Bender Jeremy | DAWN | CHIEF EXECUTIVE OFFICER | May 15 '25 | Sell | $6.26 | 13,964 | $87,385.32 | 145,737 | |
Merendino Lauren | DAWN | Chief Commercial Officer | May 15 '25 | Sell | $6.26 | 3,927 | $24,574.77 | 35,161 | |
York Charles N II | DAWN | COO, CFO AND SECRETARY | May 15 '25 | Sell | $6.26 | 4,282 | $26,796.33 | 265,231 |
DAWN Breaking Stock News: Dive into DAWN Ticker-Specific Updates for Smart Investing
GlobeNewswire
11 days ago
GOBankingRates
21 days ago
GOBankingRates
21 days ago
GOBankingRates
21 days ago
Yahoo Finance
21 days ago
The Guardian
21 days ago
Yahoo Finance Video
21 days ago
Benzinga
21 days ago
The information presented on this page, "DAWN Day One Biopharmaceuticals Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.